JPMorgan analyst James Gordon raised the firm’s price target on Grifols (GRFS) to $10.30 from $7.60 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols Completes Acquisition of Biotest Shares Following Delisting
- Grifols Announces Leadership Changes and Financial Results at June 2025 Shareholders’ Meeting
- U.S. court rules to go on with Grifol lawsuit against Gotham City, Reuters says
- Grifols SA Reports Strong Q1 2025 Financial Performance
- Grifols SA Reports Strong Q1 2025 Earnings